1. Home
  2. IPST vs MCRB Comparison

IPST vs MCRB Comparison

Compare IPST & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Distilling Holding Company Inc.

IPST

Heritage Distilling Holding Company Inc.

N/A

Current Price

$1.70

Market Cap

163.4M

ML Signal

N/A

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$15.96

Market Cap

140.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPST
MCRB
Founded
2011
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
163.4M
140.7M
IPO Year
2024
2015

Fundamental Metrics

Financial Performance
Metric
IPST
MCRB
Price
$1.70
$15.96
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$14.33
AVG Volume (30 Days)
148.7K
56.4K
Earning Date
11-18-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
55.05
0.62
Revenue
$8,294,860.00
$351,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.03
$25.78
Revenue Growth
10.26
N/A
52 Week Low
$1.12
$6.53
52 Week High
$28.40
$29.98

Technical Indicators

Market Signals
Indicator
IPST
MCRB
Relative Strength Index (RSI) N/A 51.27
Support Level N/A $15.00
Resistance Level N/A $16.42
Average True Range (ATR) 0.00 0.85
MACD 0.00 0.16
Stochastic Oscillator 0.00 82.99

Price Performance

Historical Comparison
IPST
MCRB

About IPST Heritage Distilling Holding Company Inc.

Heritage Distilling Holding Co Inc is a craft distiller producing, marketing, and selling a diverse line of award-winning craft spirits, including whiskeys, vodkas, gins, rums, and ready-to-drink canned cocktails. The company sells its products through wholesale distribution, directly to consumers through its owned and operated distilleries and tasting rooms located in Washington and Oregon, and by shipping directly to consumers online, where legal. Currently, it sells products in the Pacific Northwest with limited distribution in other states throughout the U.S.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: